Niquitin Mini (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Niquitin Mini, is a nicotine replacement therapy presented as an oromucosal formulation for oromucosal use. It treats nicotine dependence and aids smoking cessation in adult smokers.

GNH USA supplies Niquitin Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Niquitin Mini is a nicotine replacement product used to support individuals attempting to quit tobacco use.

- Smoking cessation: assists adult smokers in quitting by reducing cravings and withdrawal symptoms. - Nicotine dependence: provides controlled nicotine to alleviate physiological dependence. - Tobacco use disorder: supports reduction of cigarette consumption during quit attempts.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: transient feeling of queasiness after administration. - Hiccups: brief, involuntary diaphragm contractions. - Headache: mild to moderate discomfort. - Dizziness: temporary light‑headed sensation. - Throat irritation: scratchy feeling in the throat.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Severe mouth ulceration: persistent lesions in the oral mucosa. - Cardiovascular events: chest pain or palpitations. - Hypotension: unusually low blood pressure. - Seizures: rare neurologic episodes.

Before using Niquitin Mini, consider the following precautions: - Cardiovascular assessment: evaluate history of heart disease before initiating therapy. - Use as directed: follow prescriber instructions regarding frequency and duration. - Non‑smokers: not indicated for individuals who have never smoked. - Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously. - Pregnancy and breastfeeding: consult a healthcare professional; safety not established. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct heat.

Niquitin Mini may interact with other substances as follows:

Major Interactions (Avoid): - Other nicotine replacement products: combined use can increase nicotine exposure and risk of toxicity. - Monoamine oxidase inhibitors (MAOIs): may potentiate cardiovascular effects.

Moderate Interactions (Monitor Closely): - Certain antihypertensive agents: nicotine may counteract blood‑pressure‑lowering effects. - Psychiatric medications (e.g., antipsychotics): monitor for altered plasma levels. - Caffeine‑containing products: nicotine can enhance stimulant effects, leading to jitteriness.